[The effect of human recombinant interleukin-2 on natural cytotoxicity in patients with dilated cardiomyopathy].
Aleksandrova
E N
EN
Nasonov
E L
EL
Samsonov Miu
Aleksandrova
L Z
LZ
Naumov
V G
VG
D000293:Adolescent; D000328:Adult; D002311:Cardiomyopathy, Dilated / Q000276:immunology / Q000628:therapy*; D002478:Cells, Cultured / Q000187:drug effects / Q000276:immunology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects* / Q000276:immunology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D011994:Recombinant Proteins / Q000627:therapeutic use
D007376:Interleukin-2; D011994:Recombinant Proteins
Vliianie chelovecheskogo rekombinantnogo interleĭkina-2 na estestvennuiu tsitotoksichnost' u bol'nykh dilatatsionnoĭ kardiomiopatieĭ.